Skip to content Skip to footer
Menu Close
Close

Oncology

Hereditary Cancer Clinical Trial Focused on Cancer Prevention Through Genomic Risk Assessment

Prevent Cancer Research

Cancer Prevention Research Study

Cancer risk is not always random, as many cancers are hereditary and caused by inherited gene changes passed down in families. These mutations can increase the risk of cancers like breast, ovarian, and colorectal cancer, especially in those with a family history. Often, these risks go unnoticed until early intervention is no longer possible, highlighting the need for better understanding and preventive measures.

Zillan Clinical Research is conducting an observational study evaluating the clinical value of hereditary cancer genetic testing in adults aged 65 and older with a personal history of cancer. The study aims to understand how genetic insights can guide physicians toward better preventive measures and earlier, more targeted treatment decisions.

Check Eligibility
About This Study

Bringing Genetic Insights to Cancer Prevention Through a Hereditary Cancer Clinical Trial

Hereditary cancers account for a significant portion of cancer cases worldwide, yet many people are unaware of the genetic risks they carry. Without knowing these risks, opportunities for early prevention and timely treatment are often missed, making hereditary cancer one of the more challenging and serious health concerns for older adults.

The ongoing STOP-Cancer study is evaluating genetic testing across 16+ cancer-associated genes in adults aged 65 and older with a personal and family history of cancer who have already been prescribed medically necessary genomic testing. It seeks to understand how these results may help physicians tailor prevention and care strategies. Participation is voluntary and free of cost.

Now Enrolling

Current Status

Evaluating genetic testing to prevent hereditary cancer

Study Objective

Enroll Now
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we conduct ethical, high-quality clinical studies focused on patient safety, scientific integrity, and advancing innovative treatments for better health outcomes.

Integrity

Conducting all studies with honesty, transparency, and strict ethical standards

Patient Safety

Prioritizing participant well-being through close monitoring and care

Scientific Excellence

Following high-quality research practices and global clinical standards

Innovation

Supporting advanced research approaches that drive medical progress

Diversity & Inclusion

Ensuring studies reflect real-world patient populations

Trusted Oversight

Operating under regulated, GCP-compliant clinical research processes

FAQ

Frequently Asked Questions

This is an observational study evaluating the clinical benefits of hereditary cancer genetic testing in adults aged 65 and older with a personal and family history of cancer.

Adults aged 65 and older with a personal history of cancer and at least one blood relative with a history of cancer, whose physician has already ordered hereditary cancer genetic testing for medical necessity, may be eligible.

Yes. A hereditary cancer clinical trial is currently being conducted at Zillan Clinical Research in [Location], evaluating the real-world benefits of cancer prevention genetic testing for adults with a personal and family history of hereditary cancer.

The study evaluates whether hereditary cancer genetic testing across 16 cancer-associated genes, including BRCA1, BRCA2, and TP53, can help physicians make earlier and more informed prevention and treatment decisions.

Participants complete a survey over a 120-day observation period, covering their genetic test results, physician-recommended treatments, lifestyle changes, and medical history.

Yes. The study is conducted under strict clinical guidelines at Zillan Clinical Research, with close monitoring throughout, at no cost to participants.

Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Structured Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today